Dr Samuel McLenachan

Dr Sam McLenachan is the Senior Scientist of the Ocular Tissue Engineering Laboratory and a Lead Researcher in the Genetic Eye Disease and Gene Therapy research program at the Lions Eye Institute. Throughout his career Dr McLenachan’s research has focused on understanding and combining the elements necessary for the translation of molecular technologies into new treatments for previously incurable diseases.

Towards this end, Dr McLenachan has established a world-class disease modelling and gene therapy screening pipeline, in which skin cells collected from patients with inherited diseases can be reprogrammed to produce their own retinal tissues in the lab. These patient-derived retinal tissues represent the ideal cellular model for pre-clinical evaluation of potential therapies for incurable retinal diseases.

Drawing on a strong background in molecular, cellular and retinal biology, Dr McLenachan has developed several new approaches to the treatment of inherited retinal diseases, which are currently undergoing pre-clinical evaluation in his laboratory.

Education/academic qualifications/roles responsibilities

Awards/Professional achievements

Grants/scholarships/funding overview

Research Activity

Leading Publications

Patents

Dr Samuel McLenachan
Dr Samuel McLenachan

Genetic Eye Disease, Gene Therapies & Macular Degeneration,

Request an appointment